Workflow
人工智能多模态脑机接口平台
icon
Search documents
第十一届上交会下周开幕 14家企业(机构)首发新产品新技术
Group 1 - The 11th China (Shanghai) International Technology Import and Export Fair will be held from June 11 to 13, 2025, with the theme "Open Cooperation: Empowering New Quality Productivity and Sustainable Development" [1] - The fair will feature a total exhibition area of 35,000 square meters, including one theme pavilion, one provincial exhibition area, and four specialized technology exhibition areas [1] - Nearly 1,000 participating companies will showcase new products and technologies, with 14 companies and institutions debuting innovations, including 7 global or national premieres [1] Group 2 - The fair will highlight key technological breakthroughs from the Yangtze River Delta region and showcase innovations from the Guangdong-Hong Kong-Macao Greater Bay Area, including interactive robots and gene testing equipment [2] - Strategic emerging industries will be prominently featured, including AI solutions across various sectors, such as AI brain-computer interface platforms and AI drones [2] - Notable innovations include the world's first polar fixed-wing aircraft and a new drug for complete hepatitis B cure, showcasing significant advancements in autonomous innovation [2] Group 3 - International collaboration will be emphasized, with 46 companies from nearly 20 countries and regions presenting leading technology projects, including contributions from Glasgow and the United Nations Industrial Development Organization [3] - Since its inception in 2013, the fair has attracted over 9,500 companies from more than 30 countries and regions, facilitating over 500 intended transaction projects in recent editions [3] - Shanghai's technology import and export contract amount has seen an average annual growth of 8.6% since the 14th Five-Year Plan, reaching a historical high of $21.33 billion in 2024, a 17.7% increase year-on-year [3]
第十一届上交会将全面展示“AI+”跨行业解决方案
news flash· 2025-06-05 05:29
Core Viewpoint - The 11th Shanghai International Technology Fair will showcase "AI+" cross-industry solutions, emphasizing innovation-driven development and international technology cooperation [1] Group 1: Event Overview - The event is organized by the Shanghai Municipal Commission of Commerce and aims to accelerate Shanghai's development into a globally influential technology innovation hub [1] - A total of 180 high-tech enterprises, specialized and innovative companies, and gazelle enterprises will participate in this year's fair [1] Group 2: Featured Technologies - The fair will comprehensively display "AI+" cross-industry solutions, including: - Artificial intelligence multimodal brain-machine interface platforms - Super bionic motion robots - AI toy robots - AI drones - AI large model applications in the e-commerce sector [1]
北京天坛医院成立国内首个脑机接口临床与转化病房
Xin Jing Bao· 2025-05-17 06:06
Core Viewpoint - The establishment of the first clinical and translational ward for brain-computer interface (BCI) technology in China aims to transition BCI development from research-driven to clinically-driven applications [1][3][4]. Group 1: Clinical and Research Collaboration - The ward is a collaborative effort led by Beijing Tiantan Hospital, involving multiple research institutions such as Tsinghua University and the Chinese Academy of Sciences [3]. - It will conduct clinical trials for the "Beijing Brain No. 1" BCI device and establish a collaborative innovation system integrating medical, engineering, research, production, and government sectors [3][4]. Group 2: Training and Standards Development - The ward will organize nationwide multi-center clinical trials and develop ethical guidelines, admission standards, and clinical pathway guidelines for BCI technology [3][4]. - It aims to create a training platform for clinical doctors, engineering technicians, and researchers, fostering talent development in the BCI field [3][4]. Group 3: Technological Integration and Patient Care - The ward will feature an integrated BCI technology platform with advanced equipment for patient assessment, regulation, and training, focusing on improving the quality of life for patients with severe conditions [4]. - The goal is to transition BCI technology from prototypes to bedside applications, enhancing patient outcomes through innovative solutions [4]. Group 4: Future Vision and Impact - The director of the National Clinical Research Center for Neurological Diseases emphasized the importance of BCI as a key entry point for future medicine, aiming for breakthroughs that benefit the public [4]. - The hospital's leadership expressed commitment to leveraging its platform to transform high-level innovations into quality healthcare services, addressing public demand for improved health outcomes [4].